Menu

赛诺菲喜保宁在国内有吗?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Is Sanofi available in China? But it is a pity that Vigabatrin is not currently on the market in my country and has not been included in the Chinese medical insurance catalog. Therefore, there are no channels to purchase Vigabatrin in China. For qualified patients, they can go abroad for overseas medical treatment in person and use the doctor’s prescription to purchase Vigabatrin at local pharmacies. However, for ordinary families, it is very difficult to buy medicine locally, and it is even more impossible to go abroad for medical treatment. Therefore, it is recommended that these patients can choose domestic overseas medical institutions (Medical Companion Travel) to help purchase vigabatrin tablets (Vigabatrin), which are safe, reliable, 100% authentic, and can be delivered directly to their homes.

Sanofi is a leading global pharmaceutical and health company that researches, develops and promotes innovative treatment solutions based on patient needs. Sanofi's main businesses cover three areas: pharmaceuticals, human vaccines and animal health. According to Medical Companion Travel, we learned that the price of France's Sanofi Vigabatrin (vigabatrin), with a specification of 500 mg x 100 capsules, is around $1,450 per box. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices.

Vigabatrin (vigabatrin tablets) is an analogue of gamma-aminobutyric acid (GABA), which can irreversibly and specifically bind to GABA aminotransferase, resulting in an increase in GABA concentration in the brain, thereby fighting epilepsy. Vigabatrin can be used as an adjuvant treatment for patients who have failed other anti-epileptic drugs, and can also be used to treat patients with partial seizures (mainly used to control complex partial seizures).

The above is an introduction to whether Sanofi is available in China. For more information about Vigabatrin, please contact Medical Companion Travel for details.

Recommended related hot articles: /newsDetail/86334.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。